Veracyte Inc (VCYT)
38.94
-0.26
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
38.95
+0.01
(+0.03%)
After-Hours: 20:00
Veracyte Market Cap: 3.018B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.018B |
| November 20, 2024 | 3.038B |
| November 19, 2024 | 3.034B |
| November 18, 2024 | 2.845B |
| November 15, 2024 | 2.785B |
| November 14, 2024 | 2.871B |
| November 13, 2024 | 3.064B |
| November 12, 2024 | 2.964B |
| November 11, 2024 | 3.014B |
| November 08, 2024 | 2.827B |
| November 07, 2024 | 2.894B |
| November 06, 2024 | 2.836B |
| November 05, 2024 | 2.785B |
| November 04, 2024 | 2.711B |
| November 01, 2024 | 2.659B |
| October 31, 2024 | 2.615B |
| October 30, 2024 | 2.712B |
| October 29, 2024 | 2.664B |
| October 28, 2024 | 2.644B |
| October 25, 2024 | 2.560B |
| October 24, 2024 | 2.540B |
| October 23, 2024 | 2.515B |
| October 22, 2024 | 2.526B |
| October 21, 2024 | 2.567B |
| October 18, 2024 | 2.669B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.659B |
| October 16, 2024 | 2.690B |
| October 15, 2024 | 2.640B |
| October 14, 2024 | 2.629B |
| October 11, 2024 | 2.636B |
| October 10, 2024 | 2.501B |
| October 09, 2024 | 2.474B |
| October 08, 2024 | 2.594B |
| October 07, 2024 | 2.625B |
| October 04, 2024 | 2.545B |
| October 03, 2024 | 2.555B |
| October 02, 2024 | 2.619B |
| October 01, 2024 | 2.567B |
| September 30, 2024 | 2.638B |
| September 27, 2024 | 2.594B |
| September 26, 2024 | 2.574B |
| September 25, 2024 | 2.562B |
| September 24, 2024 | 2.591B |
| September 23, 2024 | 2.632B |
| September 20, 2024 | 2.675B |
| September 19, 2024 | 2.708B |
| September 18, 2024 | 2.593B |
| September 17, 2024 | 2.636B |
| September 16, 2024 | 2.583B |
| September 13, 2024 | 2.529B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
802.29M
Minimum
Mar 18 2020
5.432B
Maximum
Feb 09 2021
2.066B
Average
1.859B
Median
Market Cap Benchmarks
| Fonar Corp | 105.27M |
| XWELL Inc | 7.603M |
| ProPhase Labs Inc | 18.55M |
| Applied DNA Sciences Inc | 1.630M |
| OncoCyte Corp | 44.95M |
Market Cap Related Metrics
| PS Ratio | 6.946 |
| Price to Book Value | 2.566 |
| Price to Free Cash Flow | 52.31 |
| Price | 38.94 |
| Earnings Yield | -0.39% |
| Operating PE Ratio | 268.67 |
| Normalized PE Ratio | 162.73 |